(Q35824541)

10 August 2017

1 reference

title

Clinical trial design in systemic lupus erythematosus: lessons learned and future directions (English)

1 reference

systemic lupus erythematosus

10 August 2017

1 reference

1 reference

V Strand

1

1 reference

PubMed ID

15230300

10 August 2017

language of work or name

1 reference

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

13

1 reference

10 August 2017

5

1 reference

10 August 2017

406-411

1 reference

From BILAG to BLIPS--disease activity assessment in lupus past, present and future

10 August 2017

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1034OA

Oral contraceptives and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1034OA

Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1034OA

Time perspective predicts the progression of permanent organ damage in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1034OA

A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1034OA

Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1034OA

Quality of life and economic evaluation in SLE clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1034OA

Impact of disease activity and cumulative damage on the health of lupus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1034OA

Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1034OA

Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1034OA

Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1034OA

Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU1034OA

10.1191/0961203303LU1034OA

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15230300